|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-5-6
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Pneumococcal conjugate vaccine (PCV) was introduced in the United Kingdom immunization schedule in September 2006. This study was conducted to establish the immunogenicity of licensed PCV (Prevenar) at a reduced, 2 priming dose schedule (2+1) and to evaluate functional responses in the context of vaccine effectiveness.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Bacterial,
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Capsules,
http://linkedlifedata.com/resource/pubmed/chemical/Haemophilus Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Haemophilus influenzae type b...,
http://linkedlifedata.com/resource/pubmed/chemical/Measles-Mumps-Rubella Vaccine,
http://linkedlifedata.com/resource/pubmed/chemical/Meningococcal Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Pneumococcal Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Polysaccharides, Bacterial,
http://linkedlifedata.com/resource/pubmed/chemical/heptavalent pneumococcal conjugate...,
http://linkedlifedata.com/resource/pubmed/chemical/pneumococcal polysaccharide type 6,
http://linkedlifedata.com/resource/pubmed/chemical/serogroup C meningococcal...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1532-0987
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
401-5
|
|
pubmed:meshHeading |
pubmed-meshheading:20010312-Antibodies, Bacterial,
pubmed-meshheading:20010312-Bacterial Capsules,
pubmed-meshheading:20010312-Female,
pubmed-meshheading:20010312-Great Britain,
pubmed-meshheading:20010312-Haemophilus Vaccines,
pubmed-meshheading:20010312-Humans,
pubmed-meshheading:20010312-Immunization, Secondary,
pubmed-meshheading:20010312-Immunization Schedule,
pubmed-meshheading:20010312-Infant,
pubmed-meshheading:20010312-Male,
pubmed-meshheading:20010312-Measles-Mumps-Rubella Vaccine,
pubmed-meshheading:20010312-Meningococcal Vaccines,
pubmed-meshheading:20010312-Pneumococcal Vaccines,
pubmed-meshheading:20010312-Polysaccharides, Bacterial,
pubmed-meshheading:20010312-Vaccination
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United Kingdom.
|
|
pubmed:affiliation |
Immunobiology Unit, UCL Institute of Child Health, London, United Kingdom. d.goldblatt@ich.ucl.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
